Takeda Pharmaceutical Co., Ltd. (TAK)
16.16
0.00 (0.00%)
USD |
NYSE |
Jan 20, 16:00
15.84
-0.32
(-1.95%)
After-Hours: 20:00
Takeda Pharmaceutical Total Liabilities (Quarterly): 49.69B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 62.54B |
| Pfizer Inc. | 115.64B |
| Sanofi | -- |
| Nxera Pharma Co., Ltd. | 531.69M |
| Protagonist Therapeutics, Inc. | 56.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.98B |
| Shareholders Equity (Quarterly) | 48.28B |
| Debt to Equity Ratio | 0.6515 |
| Current Ratio | 1.365 |
| Net Debt Paydown Yield | 1.13% |